Polina Porotskaya is a former intern at Spectrum and a graduate student in the Science, Health and Environmental Reporting Program at New York University. Polina writes about neuroscience, biology and medicine. She has a B.A. in neuroscience from Columbia University.
Polina Porotskaya
From this contributor
Inside a summer camp for autistic children in Russia
Photographs show how a camp in St. Petersburg this summer helped children on the spectrum and their families find some fun during the pandemic.
Inside a summer camp for autistic children in Russia
Cell stress may sap organoids’ usefulness in autism research
Some cells in brain organoids — 3D clusters of cultured brain cells — fail to develop fully.
Cell stress may sap organoids’ usefulness in autism research
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Mutations in sperm may accrue too slowly to increase autism risk
A new analysis challenges the idea that mutations in the sperm of older fathers lead to higher rates of autism among their children.
Mutations in sperm may accrue too slowly to increase autism risk
New maps of neuronal connections reveal roundworms’ wiring
Two new maps show the entire nervous system of the adult roundworm Caenorhabditis elegans.
New maps of neuronal connections reveal roundworms’ wiring
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.